GlassScriptPhysician profile
Steve Lee
NPI 1699971465
$56,503.08
in general payments reported to CMS, 2019-2025
80 companies · $7,307 in 2025
The $7,307 reported for 2025 was more than what 93% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $4,033 · 2021: $2,928 · 2022: $21K · 2023: $5,469 · 2024: $5,951 · 2025: $7,307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,878 · Consulting Fee: $5,000 · Travel and Lodging: $4,849.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,877.93 |
| Consulting Fee | $5,000.00 |
| Travel and Lodging | $4,848.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Interventional Pain Technologies INC. | $14,500.00 | 2022 | |
| Nevro Corp. | $5,566.70 | 2019-2024 | Senza |
| Boston Scientific Corporation | $5,372.11 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Spinal Simplicity, LLC | $3,767.93 | 2021-2025 | Liberty Si, Ha Minuteman G3-R |
| Surgentec | $3,229.12 | 2023-2024 | Tilink, Ion, Ion Facet Screw System |
| Camber Spine Technologies LLC | $3,000.00 | 2022 | |
| Abbott Laboratories | $2,205.32 | 2019-2025 | Eterna, Proclaim, Octrode |
| Saluda Medical Americas, INC. | $2,030.22 | 2023-2025 | Evoke Scs, Evoke |
| Medtronic, INC. | $1,597.14 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Inceptiv |
| Collegium Pharmaceutical, INC. | $1,353.29 | 2019-2025 | Belbuca, Xtampza |
| Biodelivery Sciences International, INC. | $1,250.37 | 2019-2021 | |
| Genesys Orthopedics Systems, L.L.C. | $1,134.10 | 2023 | Sacroiliac Joint Fusion System |
| Relievant Medsystems, INC. | $1,028.62 | 2020-2023 | Intracept |
| Stryker Corporation | $941.95 | 2020-2025 | Mild Device Kit |
| Titan Pharmaceuticals, INC. | $779.71 | 2019-2020 |
Show all 80 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $629.19 | 2021-2024 | Nalu Neurostimulation System |
| Forte Bio-Pharma LLC | $477.42 | 2020-2024 | Prolate, Nalocet |
| Globus Medical, INC. | $463.49 | 2025 | Senza, Vyrsa V1 |
| Pacira Pharmaceuticals Incorporated | $422.23 | 2021-2023 | Iovera |
| Horizon Therapeutics Plc | $356.07 | 2019-2022 | |
| Mml US, INC. | $354.71 | 2024-2025 | Reactiv8 |
| Virtus Pharmaceuticals LLC | $344.57 | 2021-2025 | Levorphanol Tartrate |
| Arbor Pharmaceuticals, INC. | $339.02 | 2019-2022 | |
| Ibsa Pharma INC. | $336.69 | 2020-2025 | Tirosint, Licart, Licart |
| Amgen INC. | $315.47 | 2021-2024 | Uplizna, Aimovig |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $268.34 | 2019-2025 | Relistor |
| Medtronic USA, INC. | $256.59 | 2019-2020 | |
| Abbvie INC. | $215.64 | 2021-2025 | |
| Stratus Medical, LLC | $214.43 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $206.11 | 2022 | |
| Sentynl Therapeutics, INC. | $199.06 | 2019-2020 | |
| Vertiflex, INC. | $181.43 | 2019 | |
| Almatica Pharma LLC | $154.93 | 2021-2023 | Gralise |
| Biotronik Nro, INC. | $143.28 | 2025 | Prospera |
| Spr Therapeutics, INC | $142.30 | 2019-2025 | Sprint Pns System |
| Painteq LLC | $139.52 | 2021-2023 | Painteq |
| Tersera Therapeutics LLC | $137.44 | 2019-2023 | Prialt |
| Indivior INC. | $137.38 | 2019-2025 | Sublocade |
| Nutech Spine, INC. | $130.36 | 2022 | |
| Stimwave Technologies Incorporated | $128.50 | 2021-2022 | |
| Zyla Life Sciences, INC. | $126.04 | 2019-2020 | |
| Genzyme Corporation | $124.83 | 2019 | |
| Grt US Holding, INC. | $123.97 | 2020-2022 | |
| Curonix LLC | $108.84 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Mdd US Operations, LLC | $106.45 | 2019 | |
| Pfizer INC. | $105.15 | 2019-2022 | |
| Redhill Biopharma INC. | $93.23 | 2020-2021 | |
| Bioventus LLC | $90.75 | 2023-2025 | Stimrouter Implantable Kit, Durolane, Durolane |
| Vertex Pharmaceuticals Incorporated | $90.65 | 2025 | |
| Azurity Pharmaceuticals, INC. | $86.95 | 2023-2025 | Horizant, Horizant |
| Scilex Pharmaceuticals INC. | $83.31 | 2019-2024 | Ztlido |
| Daiichi Sankyo INC. | $81.79 | 2019 | |
| Allergan, INC. | $81.07 | 2019-2021 | |
| Supernus Pharmaceuticals, INC. | $75.25 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $68.46 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $59.62 | 2020 | |
| Alkermes, INC. | $52.22 | 2019-2021 | |
| Orexo US, INC. | $48.83 | 2019-2022 | |
| Vertos Medical, INC. | $35.32 | 2019 | |
| Pacira Therapeutics, INC. | $25.98 | 2019-2020 | |
| Merz North America, INC. | $25.90 | 2023 | Xeomin |
| Upsher-Smith Laboratories LLC | $24.87 | 2022 | |
| Fidia Pharma USA INC. | $24.64 | 2024 | Hymovis, Hyalgan, Triluron |
| Assertio Therapeutics, INC. | $23.19 | 2019 | |
| Baudax Bio INC. | $22.85 | 2022 | |
| Lundbeck LLC | $22.38 | 2022 | |
| Jazz Pharmaceuticals INC. | $20.33 | 2023 | Epidiolex |
| Convatec INC. | $20.31 | 2024 | |
| Neurocrine Biosciences, INC. | $19.97 | 2022 | |
| Novartis Pharmaceuticals Corporation | $19.76 | 2021 | |
| Impel Pharmaceuticals INC. | $19.26 | 2023 | Trudhesa |
| Alfasigma USA, INC. | $19.15 | 2022 | |
| Braeburn INC. | $18.87 | 2023 | Brixadi |
| Teva Pharmaceuticals USA, INC. | $18.61 | 2021 | |
| Valinor Pharma, LLC | $16.13 | 2025 | Movantik |
| Flowonix Medical Incorporated | $15.78 | 2020 | |
| Grifols USA, LLC | $14.02 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.67 | 2023 | Seglentis |
| Shionogi INC | $12.38 | 2019 | |
| Metacel Pharmaceuticals LLC | $11.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steve Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.